about
Molecular pathogenesis and clinical consequences of iron overload in liver cirrhosis.The role of MR imaging in detection of hepatic iron overload in patients with cirrhosis of different origins.Interferon lambda polymorphisms associate with body iron indices and hepatic expression of interferon-responsive long non-coding RNA in chronic hepatitis C.Association of hepcidin mRNA expression with hepatocyte iron accumulation and effects of antiviral therapy in chronic hepatitis C infection.The iron homeostasis network and hepatitis C virus - a new challenge in the era of directly acting antiviralsEffectiveness and safety of ledipasvir/sofosbuvir±ribavirin in the treatment of HCV infection: The real-world HARVEST study.Analysis of polymorphism and hepatic expression of duodenal cytochrome b in chronic hepatitis C.Is there any association between HCV multiplication and iron induced liver injury in chronic hepatitis C?Hepatitis delta virus infection in chronically HBV-infected patients from northern Poland.Liver steatosis correlates with iron overload but not with HFE gene mutations in chronic hepatitis C.Hepatitis D, B and C virus (HDV/HBV/HCV) coinfection as a diagnostic problem and therapeutic challengeCompound heterozygote (C282Y/H63D) of hereditary hemochromatosis in a 16-year-old girl with hypoplastic kidneyUGT1A1 gene polymorphism as a potential factor inducing iron overload in the pathogenesis of type 1 hereditary hemochromatosisIron overload and HFE gene mutations in Polish patients with liver cirrhosisEfficacy of HCV treatment in Poland at the turn of the interferon era - the EpiTer studyPrevalence of HCV genotypes in Poland - the EpiTer studyCoronavirus Disease 2019 as a challenge for maritime medicineCan two-dimensional speckle tracking echocardiography be useful for left ventricular assessment in the early stages of hereditary haemochromatosis?Neutrocyte-to-lymphocyte ratio predicts the presence of a replicative hepatitis C virus strand after therapy with direct-acting antivirals
P50
Q30244634-3C049554-AC6F-497D-BAFD-7AD28A54CB94Q33526884-638A2777-130F-4668-A8C9-F3F3B0F5657AQ33600034-00A25011-7D68-4C4F-B2BC-AAB3EA302030Q34864591-E1E0CBE9-999B-4C93-819E-299AA8BFFE44Q37189852-4D420BF0-EAC5-4AD3-B2B3-6E410B1A3F24Q39006501-494BA9B9-EEE0-4F1D-AC43-1A4BB8AF6805Q39413233-DC37516B-5245-4389-816E-CFFE36595633Q43033166-4A1E5B77-1547-4478-AA48-59092E11128CQ45421233-6CFE8FFF-8296-4A08-B732-51B857DD1662Q47835684-FF2ACA39-30C7-4A94-B36B-5693D4AD8AC9Q56947386-4765B0C0-22BD-43E0-8AFC-F31FCE44798BQ80273696-6980F475-50B0-44ED-B19D-532BD238C93EQ83325376-B8F53BFD-E542-46DA-9034-D69F360D5A7CQ84351336-7A629500-C799-4EBC-9E2A-B43A84F556BDQ88881146-8EFC5D98-5AFD-413F-9B10-973683F776F7Q88881150-B0F56CA4-EFD6-472A-80E6-7AF50201A7EEQ90648723-039CEC64-22A3-467C-874C-E709D1CA0957Q91749982-DDBB1D83-2467-42B4-8ED1-A81A60330BC8Q92284224-3B7E520B-18DC-46EE-A0D5-784FB9962625
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Katarzyna Sikorska
@ast
Katarzyna Sikorska
@en
Katarzyna Sikorska
@es
Katarzyna Sikorska
@nl
type
label
Katarzyna Sikorska
@ast
Katarzyna Sikorska
@en
Katarzyna Sikorska
@es
Katarzyna Sikorska
@nl
prefLabel
Katarzyna Sikorska
@ast
Katarzyna Sikorska
@en
Katarzyna Sikorska
@es
Katarzyna Sikorska
@nl
P106
P1153
6602482534
P31
P496
0000-0001-5678-5669